欧盟官方标签名称词汇表条目 8449
DIBROMOHEXAMIDINE ISETHIONATE
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 5 个有匹配的监管证据:4 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
5
证据缺口
8
已解析的标识符
2
已解析的物质身份
CAS:93856-83-8
EC:299-116-4
成分索引记录:
DIBROMOHEXAMIDINE ISETHIONATE
化妆品功能: PRESERVATIVE
2-Hydroxyethanesulphonic acid, compound with 4,4'-[Hexane-1,6-diylbis(oxy)]bis[3-bromobenzenecarboxamidine] (2:1)
清单限制备注: V/15
7 个匹配或报告的名称
DIBROMOHEXAMIDINE ISETHIONATEDibromohexamidine isethionate3,3'-Dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts (including isethionate)Dibromohexamidine Isethionate3,3′-Dibromo-4,4′-hexamethylenedioxydibenzamidine (dibromohexamidine) and its salts, including isethionate e.g. dibromohexamidine isethionate3,3'-Dibromo-4,4'-hexamethylenedioxydi- benzamidine (Dibromohexamidine) and its salts ( including isethionate) (CAS No. 93856-83-8)디브로모헥사미딘및 그 염류(이세치오네이트포함)
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 有条件准用清单匹配 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | Permitted list with conditions | 1打开记录 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Permitted list with conditions | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | Permitted list with conditions | 1打开记录 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条关联记录及其确切条件。 |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1打开记录 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026附件 II–VI 的精确证据
化学身份与性质

CAS 93856-83-8PubChem CID 153876
2-Hydroxyethanesulphonic acid, compound with 4,4'-(hexane-1,6-diylbis(oxy))bis(3-bromobenzenecarboxamidine) (2:1)
- IUPAC 名称
- 3-bromo-4-[6-(2-bromo-4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide;bis(2-hydroxyethanesulfonic acid)
- 分子式
- C24H36Br2N4O10S2
- 分子量
- 764.5 g/mol
- 精确质量
- 764.02191 Da
- 拓扑极性表面积
- 284.0 Ų
- 氢键供体
- 8
- 氢键受体
- 12
- 共价单元
- 3
- 已定义的立体中心
- 0
又称
EINECS 299-116-42-hydroxyethanesulphonic acid, compound with 4,4'-[hexane-1,6-diylbis(oxy)]bis[3-bromobenzenecarboxamidine] (2:1)RefChem:473420299-116-42-Hydroxyethane-1-sulfonic acid--4,4'-[hexane-1,6-diylbis(oxy)]bis(3-bromobenzene-1-carboximidamide) (2/1)
外部数据库标识符
- EPA DTXSID:DTXSID20150576
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定